author-photo

Donald Small

Johns Hopkins University School of Medicine
Boston University
Johns Hopkins University

423

Papers

28450

Citations

Citation Trend

Filter By

Papers (423) Sort By

Journal Conference Others

FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (3)
Deletions in FLT-3 juxtamembrane domain define a new class of pathogenic mutations: case report and systematic analysis

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (2)
A Phase 1a/1b First in Human Study of PHI-101, a Potent Small Molecule Inhibitor of FLT3 in Relapsed and Refractory Acute Myeloid Leukemia

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A method for overcoming plasma protein inhibition of tyrosine kinase inhibitors.

2021 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (0)
Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631 (Leukemia, (2021), 35, 5, (1279-1290), 10.1038/s41375-021-01177-6)

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation.

2021 Signal Transduction and Targeted Therapy
Show All
- Source
- Cite
- Save
Citations (3)
PHI-101 Is a Potent Third-Generation FLT3 Inhibitor Developed to Overcome Resistance in Acute Myeloid Leukemia

2020 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Abstract 4226: PHI-101, a next generation FLT3 inhibitor for acute myeloid leukemia

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A novel RBMX‐TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor

2019 Genes, Chromosomes and Cancer
Show All
- Source
- Cite
- Save
Citations (17)
Gilteritinib and Venetoclax Synergize to Eliminate FLT3/ITD+ Leukemia Cells through BIM

2019 Blood
Show All
- Source
- Cite
- Save
Citations (2)